DRC & Research News

This page shares the latest news in T1D research and DRC’s community.

Get the most recent diabetes research news, delivered straight to your inbox

Brusko headshot

Dr. Todd Brusko’s Project Fully Funded on Day 1

Welcome! Today, we are going to explore an exciting field of research, potentially game-changing for the millions living with Type 1 Diabetes. We are diving into the world of Dr. Todd Brusko and his ground-breaking research. This research, fully funded on day one with a whopping $60,000, aims to engineer a patient’s immune cells, trying to halt the autoimmune attack causing Type 1 Diabetes. Intriguing, right? Let’s delve into it!

Understanding Type 1 Diabetes with Dr. Todd Brusko

Understanding Immune System’s Role

In a nutshell, Type 1 Diabetes is an autoimmune disorder where the body’s immune system mistakenly attacks the insulin-producing beta cells in the pancreas. But, what if we could tweak this misbehavior?

Symptoms and Complications

From frequent urination, constant hunger to blurry vision, the symptoms can be severe. If left unchecked, long-term complications such as heart disease and nerve damage can occur.

Dr. Todd Brusko and His Research

Research Background

Enter Dr. Todd Brusko. A respected figure in the field, Dr. Brusko has dedicated his career to understanding the role of T-cells in autoimmune diseases like Type 1 Diabetes.

The $60,000 Project

Backed by a strong team and fueled by a $60,000 funding that was fully pledged on day one, Dr. Brusko’s research has gained significant attention and momentum.

Can We Engineer Immune Cells?

Theoretical Background

But, how can we engineer immune cells to fight an autoimmune disorder? It’s like attempting to teach a dog not to fetch, right?

Mechanism and Research Findings

Actually, not quite. Dr. Todd Brusko’s research is based on a breakthrough concept of reengineering T-cells to prevent them from attacking the pancreas. Excitingly, early research findings are promising.

Implications of Dr. Todd Brusko’s Research

For Diabetes Treatment

Should Dr. Todd Brusko’s project succeed, it could potentially revolutionize diabetes treatment, turning it from management to cure.

For Autoimmune Disorders

And it’s not just diabetes. The implications could extend to other autoimmune disorders, offering hope to millions.

The Path Forward for Dr. Todd Brusko

Despite the excitement, the path forward is not without its challenges.

Potential Challenges for Dr. Todd Brusko

Scientific Challenges

The biggest hurdle is the scientific challenge. How do we make the immune cells stop their destructive behavior without suppressing their protective roles?

Regulatory and Ethical Challenges

Beyond the scientific obstacles, regulatory and ethical issues need careful navigation.

The Role of Funding

With research of this nature, funding plays a critical role.

Importance of Early Funding

This is where the $60,000 project comes in. Early funding, like the full pledge on day one, helps to kickstart the research and keep it going.

Crowdfunding and Medical Research

Crowdfunding, as demonstrated in Dr. Todd Brusko’s project, has become a game-changer in medical research funding.


Dr. Todd Brusko’s pioneering work is a beacon of hope for people living with Type 1 Diabetes. The road to a potential cure is fraught with challenges but backed by the unwavering support of donors, promising early results, and a dedicated research team, the prospect of engineering a patient’s immune cells to halt the autoimmune attack seems within reach.


  1. What is the main focus of Dr. Todd Brusko’s research?
    • Dr. Todd Brusko’s research focuses on engineering immune cells to stop them from attacking the pancreas, the cause of Type 1 Diabetes.
  2. How was the $60,000 project funded?
    • The $60,000 project was fully funded on its first day, demonstrating significant support and belief in Dr. Brusko’s research.
  3. What potential impact could Dr. Todd Brusko’s research have?
    • If successful, the research could revolutionize the treatment of Type 1 Diabetes and potentially other autoimmune disorders.
  4. What are the challenges ahead?
    • The challenges ahead include scientific hurdles, regulatory issues, and ethical considerations.
  5. What role does funding play in this type of research?
    • Funding is crucial in such groundbreaking research. It helps kickstart the project and sustains it throughout its course.


Donors were so excited to read about Dr. Brusko’s project, “Can we engineer a patient’s immune cells to stop the autoimmune attack that causes type 1 diabetes?” that they plunked down the whole $60,000 at The Diabetes Research Connection’s website launch party on Friday, 11/14/2014.

We are thrilled by this unexpected but welcome response to our website, and invite you to look at and consider supporting the other two meritorious and novel projects posted on our site under SUBMIT A PROJECT. Contributions of any amount are greatly appreciated. Let’s get these projects up and running!

Dr. Todd Brusko'

Learn More +


See our approved research projects and campaigns.

Role of the integrated stress response in type 1 diabetes pathogenesis
In individuals with type 1 diabetes (T1D), the insulin-producing beta cells are spontaneously destroyed by their own immune system. The trigger that provokes the immune system to destroy the beta cells is unknown. However, accumulating evidence suggest that signals are perhaps first sent out by the stressed beta cells that eventually attracts the immune cells. Stressed cells adapt different stress mitigation systems as an adaptive response. However, when these adaptive responses go awry, it results in cell death. One of the stress response mechanisms, namely the integrated stress response (ISR) is activated under a variety of stressful stimuli to promote cell survival. However, when ISR is chronically activated, it can be damaging to the cells and can lead to cell death. The role of the ISR in the context of T1D is unknown. Therefore, in this DRC funded study, we propose to study the ISR in the beta cells to determine its role in propagating T1D.
Wearable Skin Fluorescence Imaging Patch for the Detection of Blood Glucose Level on an Engineered Skin Platform
A Potential Second Cure for T1D by Re-Educating the Patient’s Immune System
L Ferreira
Validating the Hypothesis to Cure T1D by Eliminating the Rejection of Cells From Another Person by Farming Beta Cells From a Patient’s Own Stem Cells
Han Zhu
Taming a Particularly Lethal Category of Cells May Reduce/Eliminate the Onset of T1D
JRDwyer 2022 Lab 1
Can the Inhibition of One Specific Body Gene Prevent Type 1 Diabetes?
Is Cholesterol Exacerbating T1D by Reducing the Functionality and Regeneration Ability of Residual Beta Cells?
Regeneration Ability of Residual Beta Cells
A Call to Question… Is T1D Caused by Dysfunctionality of Two Pancreatic Cells (β and α)?
Xin Tong
Novel therapy initiative with potential path to preventing T1D by targeting TWO components of T1D development (autoimmune response and beta-cell survival)
flavia pecanha